EICHOR
● Recruiting
Single Bolus Non-immunogenic Staphylokinase in Patients With Acute Ischemic Stroke Within 4.5-24 Hours of Symptom Onset
Condition: Ischemic Stroke, Acute · Sponsor: Supergene, LLC
About this study
Multicenter, double-blind, randomized, placebo-controlled phase III clinical trial. At the clinical sites, patients with acute ischemic stroke within 4.5-24 hours of symptom onset will be randomized to receive a single bolus injection of the recombinant non-immunogenic staphylokinase (Fortelyzin®, LLC "SuperGene", Russia) or placebo.
This description comes directly from the study's public registry record.
Talk to the study team
Nikolay A. Shamalov, MD, prof · (499) 936-99-37 · shamalovn@gmail.com
Natalya A. Marskaya · (499) 936-99-37 · marskayana@gmail.com
Always discuss trial participation with your own doctor first.
Locations (22)
| Ryazan Regional Clinical Hospital | Ryazan, Ryazan Oblast, Russia | Not Yet Recruiting |
| Altai Regional Clinical Hospital | Barnaul, Russia | Not Yet Recruiting |
| Chelyabinsk Regional Clinical Hospital No. 3 | Chelyabinsk, Russia | Not Yet Recruiting |
| Irkutsk Regional Clinical Hospital | Irkutsk, Russia | Recruiting |
| Kaluga Regional Clinical Hospital | Kaluga, Russia | Not Yet Recruiting |
| Interregional Clinical and Diagnostic Center | Kazan', Russia | Not Yet Recruiting |
| S.V. Ochapovsky Research Institute - Regional Clinical Hospital No. 1 | Krasnodar, Russia | Recruiting |
| Krasnogorsk Clinical Hospital | Krasnogorsk, Russia | Not Yet Recruiting |
| F.I. Inozemtsev Moscow City Clinical Hospital | Moscow, Russia | Not Yet Recruiting |
| Moscow Multidisciplinary Clinical Center "Kommunarka" | Moscow, Russia | Not Yet Recruiting |
| N.I. Pirogov Russian National Research Medical University | Moscow, Russia | Not Yet Recruiting |
| L.A. Vorokhobov Moscow City Clinical Hospital No. 67 | Moscow, Russia | Not Yet Recruiting |
+ 10 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.